Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study

Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as assessed by transient elastography, remains controversial. Seven hundred and fifty‐five patients with CHB and normal serum alanine aminotransferase leve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of viral hepatitis 2022-03, Vol.29 (3), p.196-204
Hauptverfasser: Wang, Xiao‐Dong, Pan, Chen‐Wei, Zhou, Guang‐Yao, Gao, Feng, Wang, Feng‐Ling, Fu, Rong‐Quan, Xiao, Er‐Hui, Li, Peng, Zhang, Huai, Zheng, Ming‐Hua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 204
container_issue 3
container_start_page 196
container_title Journal of viral hepatitis
container_volume 29
creator Wang, Xiao‐Dong
Pan, Chen‐Wei
Zhou, Guang‐Yao
Gao, Feng
Wang, Feng‐Ling
Fu, Rong‐Quan
Xiao, Er‐Hui
Li, Peng
Zhang, Huai
Zheng, Ming‐Hua
description Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as assessed by transient elastography, remains controversial. Seven hundred and fifty‐five patients with CHB and normal serum alanine aminotransferase levels, who underwent vibration‐controlled transient elastography and liver biopsy, were included in the study. We examined whether the histological degree of liver steatosis affects the accuracy of transient elastography‐assessed LSM in these patients. Among the 755 CHB patients included in the study, 286 (37.9%) had liver steatosis, of whom 156 had grade S1, 74 had grade S2, and 56 had grade S3 on histology. Presence of liver steatosis was independently associated with greater body mass index (BMI, adjusted‐odds ratio [OR] = 5.786, 95% CI: 3.998–8.373, p = 0.018), and higher serum total cholesterol (adjusted‐OR = 7.944, 95% CI: 4.731–13.339, p 
doi_str_mv 10.1111/jvh.13640
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610074278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2630567119</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-8c98c204b37d0669a5ee6c1327e69c1c5f1495f452ea92aa716c187397b877fd3</originalsourceid><addsrcrecordid>eNp1kc9uFDEMxkcIREvhwAugSFzgMG3-TCYTbm1VKKgSF-A6ymYdTVaTZIkzW-0L8Zxk2dIDEr7Yin_-YutrmteMnrMaF5vddM5E39EnzWnNsuWDFk8PteQtlbQ7aV4gbihlgkv2vDkRnaacs_60-XXjHNhCkiOz30EmWMCUhB5Jio9P3rkIiCSAwSVDgFiIj8ROOUVvyQRbU3ypM1fkUNU2kntfJhJTDmYmCHkJxMwm-gjEBB9TySaig2wQyAw7mPEDuSRhmYu3dT4DsWlKudTfl_X-ZfPMmRnh1UM-a75_vPl2fdveff30-fryrrVCCtoOVg-W024l1Jr2vTYSoLf1agW9tsxKxzotXSc5GM2NUax2ByW0Wg1KubU4a94ddbc5_VwAyxg8Wpjr5pAWHHnPKFUdV0NF3_6DbtKSY92uUoLKXjGmK_X-SNmcEDO4cZt9MHk_MjoezBureeMf8yr75kFxWQVYP5J_3arAxRG49zPs_680fvlxe5T8DbjTpmY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2630567119</pqid></control><display><type>article</type><title>Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wang, Xiao‐Dong ; Pan, Chen‐Wei ; Zhou, Guang‐Yao ; Gao, Feng ; Wang, Feng‐Ling ; Fu, Rong‐Quan ; Xiao, Er‐Hui ; Li, Peng ; Zhang, Huai ; Zheng, Ming‐Hua</creator><creatorcontrib>Wang, Xiao‐Dong ; Pan, Chen‐Wei ; Zhou, Guang‐Yao ; Gao, Feng ; Wang, Feng‐Ling ; Fu, Rong‐Quan ; Xiao, Er‐Hui ; Li, Peng ; Zhang, Huai ; Zheng, Ming‐Hua</creatorcontrib><description>Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as assessed by transient elastography, remains controversial. Seven hundred and fifty‐five patients with CHB and normal serum alanine aminotransferase levels, who underwent vibration‐controlled transient elastography and liver biopsy, were included in the study. We examined whether the histological degree of liver steatosis affects the accuracy of transient elastography‐assessed LSM in these patients. Among the 755 CHB patients included in the study, 286 (37.9%) had liver steatosis, of whom 156 had grade S1, 74 had grade S2, and 56 had grade S3 on histology. Presence of liver steatosis was independently associated with greater body mass index (BMI, adjusted‐odds ratio [OR] = 5.786, 95% CI: 3.998–8.373, p = 0.018), and higher serum total cholesterol (adjusted‐OR = 7.944, 95% CI: 4.731–13.339, p &lt; 0.001) and triglyceride levels (adjusted‐OR = 2.777, 95% CI: 2.050–3.761, p &lt; 0.001). There was no significant association between liver steatosis and fibrosis stage (OR = 1.016, 95% CI: 0.905–1.140, p = 0.790). Age (B‐coefficient = 0.020, 95% CI: 0.001–0.040, p = 0.044), BMI (B‐coefficient = 0.060, 95% CI: 0.011–0.127, p = 0.019), serum gamma‐glutamyl‐transpeptidase (GGT, B‐coefficient = 0.015, 95% CI: 0.001–0.029, p = 0.032), positivity for HBeAg (B‐coefficient = −0.816, 95% CI: −1.568 to −0.064, p = 0.034), as well as liver fibrosis stage (B‐coefficient = 2.796, 95% CI: 2.501–3.090, p &lt; 0.001), and inflammation activity grade (B‐coefficient = 0.648, 95% CI: 0.162–1.135, p = 0.009) were all independently associated with higher LSM, while no significant association was found between degree of liver steatosis and LSM. Among patients with the same histological fibrosis stage, LSM values did not show any significant difference among patients with absent, mild, moderate or severe steatosis. We conclude that liver steatosis has no significant effect on transient elastography‐measured LSM in CHB patients with normal serum alanine aminotransferase levels.</description><identifier>ISSN: 1352-0504</identifier><identifier>EISSN: 1365-2893</identifier><identifier>DOI: 10.1111/jvh.13640</identifier><identifier>PMID: 34902216</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Alanine ; alanine aminotransferase ; Alanine Transaminase ; Biopsy ; Body mass index ; Cholesterol ; chronic hepatitis B ; Cohort analysis ; Cohort Studies ; Elasticity Imaging Techniques ; Fatty liver ; Fatty Liver - pathology ; Fibrosis ; Hepatitis ; Hepatitis B ; Hepatitis B e antigen ; Hepatitis B, Chronic - complications ; Hepatitis B, Chronic - pathology ; Humans ; Interferon ; Liver ; Liver - diagnostic imaging ; Liver - pathology ; Liver Cirrhosis - complications ; liver fibrosis ; liver steatosis ; liver stiffness measurement ; Steatosis</subject><ispartof>Journal of viral hepatitis, 2022-03, Vol.29 (3), p.196-204</ispartof><rights>2021 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2022 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-8c98c204b37d0669a5ee6c1327e69c1c5f1495f452ea92aa716c187397b877fd3</citedby><cites>FETCH-LOGICAL-c3530-8c98c204b37d0669a5ee6c1327e69c1c5f1495f452ea92aa716c187397b877fd3</cites><orcidid>0000-0003-4984-2631</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjvh.13640$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjvh.13640$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34902216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xiao‐Dong</creatorcontrib><creatorcontrib>Pan, Chen‐Wei</creatorcontrib><creatorcontrib>Zhou, Guang‐Yao</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Wang, Feng‐Ling</creatorcontrib><creatorcontrib>Fu, Rong‐Quan</creatorcontrib><creatorcontrib>Xiao, Er‐Hui</creatorcontrib><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Zhang, Huai</creatorcontrib><creatorcontrib>Zheng, Ming‐Hua</creatorcontrib><title>Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study</title><title>Journal of viral hepatitis</title><addtitle>J Viral Hepat</addtitle><description>Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as assessed by transient elastography, remains controversial. Seven hundred and fifty‐five patients with CHB and normal serum alanine aminotransferase levels, who underwent vibration‐controlled transient elastography and liver biopsy, were included in the study. We examined whether the histological degree of liver steatosis affects the accuracy of transient elastography‐assessed LSM in these patients. Among the 755 CHB patients included in the study, 286 (37.9%) had liver steatosis, of whom 156 had grade S1, 74 had grade S2, and 56 had grade S3 on histology. Presence of liver steatosis was independently associated with greater body mass index (BMI, adjusted‐odds ratio [OR] = 5.786, 95% CI: 3.998–8.373, p = 0.018), and higher serum total cholesterol (adjusted‐OR = 7.944, 95% CI: 4.731–13.339, p &lt; 0.001) and triglyceride levels (adjusted‐OR = 2.777, 95% CI: 2.050–3.761, p &lt; 0.001). There was no significant association between liver steatosis and fibrosis stage (OR = 1.016, 95% CI: 0.905–1.140, p = 0.790). Age (B‐coefficient = 0.020, 95% CI: 0.001–0.040, p = 0.044), BMI (B‐coefficient = 0.060, 95% CI: 0.011–0.127, p = 0.019), serum gamma‐glutamyl‐transpeptidase (GGT, B‐coefficient = 0.015, 95% CI: 0.001–0.029, p = 0.032), positivity for HBeAg (B‐coefficient = −0.816, 95% CI: −1.568 to −0.064, p = 0.034), as well as liver fibrosis stage (B‐coefficient = 2.796, 95% CI: 2.501–3.090, p &lt; 0.001), and inflammation activity grade (B‐coefficient = 0.648, 95% CI: 0.162–1.135, p = 0.009) were all independently associated with higher LSM, while no significant association was found between degree of liver steatosis and LSM. Among patients with the same histological fibrosis stage, LSM values did not show any significant difference among patients with absent, mild, moderate or severe steatosis. We conclude that liver steatosis has no significant effect on transient elastography‐measured LSM in CHB patients with normal serum alanine aminotransferase levels.</description><subject>Alanine</subject><subject>alanine aminotransferase</subject><subject>Alanine Transaminase</subject><subject>Biopsy</subject><subject>Body mass index</subject><subject>Cholesterol</subject><subject>chronic hepatitis B</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Elasticity Imaging Techniques</subject><subject>Fatty liver</subject><subject>Fatty Liver - pathology</subject><subject>Fibrosis</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B e antigen</subject><subject>Hepatitis B, Chronic - complications</subject><subject>Hepatitis B, Chronic - pathology</subject><subject>Humans</subject><subject>Interferon</subject><subject>Liver</subject><subject>Liver - diagnostic imaging</subject><subject>Liver - pathology</subject><subject>Liver Cirrhosis - complications</subject><subject>liver fibrosis</subject><subject>liver steatosis</subject><subject>liver stiffness measurement</subject><subject>Steatosis</subject><issn>1352-0504</issn><issn>1365-2893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9uFDEMxkcIREvhwAugSFzgMG3-TCYTbm1VKKgSF-A6ymYdTVaTZIkzW-0L8Zxk2dIDEr7Yin_-YutrmteMnrMaF5vddM5E39EnzWnNsuWDFk8PteQtlbQ7aV4gbihlgkv2vDkRnaacs_60-XXjHNhCkiOz30EmWMCUhB5Jio9P3rkIiCSAwSVDgFiIj8ROOUVvyQRbU3ypM1fkUNU2kntfJhJTDmYmCHkJxMwm-gjEBB9TySaig2wQyAw7mPEDuSRhmYu3dT4DsWlKudTfl_X-ZfPMmRnh1UM-a75_vPl2fdveff30-fryrrVCCtoOVg-W024l1Jr2vTYSoLf1agW9tsxKxzotXSc5GM2NUax2ByW0Wg1KubU4a94ddbc5_VwAyxg8Wpjr5pAWHHnPKFUdV0NF3_6DbtKSY92uUoLKXjGmK_X-SNmcEDO4cZt9MHk_MjoezBureeMf8yr75kFxWQVYP5J_3arAxRG49zPs_680fvlxe5T8DbjTpmY</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Wang, Xiao‐Dong</creator><creator>Pan, Chen‐Wei</creator><creator>Zhou, Guang‐Yao</creator><creator>Gao, Feng</creator><creator>Wang, Feng‐Ling</creator><creator>Fu, Rong‐Quan</creator><creator>Xiao, Er‐Hui</creator><creator>Li, Peng</creator><creator>Zhang, Huai</creator><creator>Zheng, Ming‐Hua</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4984-2631</orcidid></search><sort><creationdate>202203</creationdate><title>Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study</title><author>Wang, Xiao‐Dong ; Pan, Chen‐Wei ; Zhou, Guang‐Yao ; Gao, Feng ; Wang, Feng‐Ling ; Fu, Rong‐Quan ; Xiao, Er‐Hui ; Li, Peng ; Zhang, Huai ; Zheng, Ming‐Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-8c98c204b37d0669a5ee6c1327e69c1c5f1495f452ea92aa716c187397b877fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alanine</topic><topic>alanine aminotransferase</topic><topic>Alanine Transaminase</topic><topic>Biopsy</topic><topic>Body mass index</topic><topic>Cholesterol</topic><topic>chronic hepatitis B</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Elasticity Imaging Techniques</topic><topic>Fatty liver</topic><topic>Fatty Liver - pathology</topic><topic>Fibrosis</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B e antigen</topic><topic>Hepatitis B, Chronic - complications</topic><topic>Hepatitis B, Chronic - pathology</topic><topic>Humans</topic><topic>Interferon</topic><topic>Liver</topic><topic>Liver - diagnostic imaging</topic><topic>Liver - pathology</topic><topic>Liver Cirrhosis - complications</topic><topic>liver fibrosis</topic><topic>liver steatosis</topic><topic>liver stiffness measurement</topic><topic>Steatosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xiao‐Dong</creatorcontrib><creatorcontrib>Pan, Chen‐Wei</creatorcontrib><creatorcontrib>Zhou, Guang‐Yao</creatorcontrib><creatorcontrib>Gao, Feng</creatorcontrib><creatorcontrib>Wang, Feng‐Ling</creatorcontrib><creatorcontrib>Fu, Rong‐Quan</creatorcontrib><creatorcontrib>Xiao, Er‐Hui</creatorcontrib><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Zhang, Huai</creatorcontrib><creatorcontrib>Zheng, Ming‐Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of viral hepatitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xiao‐Dong</au><au>Pan, Chen‐Wei</au><au>Zhou, Guang‐Yao</au><au>Gao, Feng</au><au>Wang, Feng‐Ling</au><au>Fu, Rong‐Quan</au><au>Xiao, Er‐Hui</au><au>Li, Peng</au><au>Zhang, Huai</au><au>Zheng, Ming‐Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study</atitle><jtitle>Journal of viral hepatitis</jtitle><addtitle>J Viral Hepat</addtitle><date>2022-03</date><risdate>2022</risdate><volume>29</volume><issue>3</issue><spage>196</spage><epage>204</epage><pages>196-204</pages><issn>1352-0504</issn><eissn>1365-2893</eissn><abstract>Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as assessed by transient elastography, remains controversial. Seven hundred and fifty‐five patients with CHB and normal serum alanine aminotransferase levels, who underwent vibration‐controlled transient elastography and liver biopsy, were included in the study. We examined whether the histological degree of liver steatosis affects the accuracy of transient elastography‐assessed LSM in these patients. Among the 755 CHB patients included in the study, 286 (37.9%) had liver steatosis, of whom 156 had grade S1, 74 had grade S2, and 56 had grade S3 on histology. Presence of liver steatosis was independently associated with greater body mass index (BMI, adjusted‐odds ratio [OR] = 5.786, 95% CI: 3.998–8.373, p = 0.018), and higher serum total cholesterol (adjusted‐OR = 7.944, 95% CI: 4.731–13.339, p &lt; 0.001) and triglyceride levels (adjusted‐OR = 2.777, 95% CI: 2.050–3.761, p &lt; 0.001). There was no significant association between liver steatosis and fibrosis stage (OR = 1.016, 95% CI: 0.905–1.140, p = 0.790). Age (B‐coefficient = 0.020, 95% CI: 0.001–0.040, p = 0.044), BMI (B‐coefficient = 0.060, 95% CI: 0.011–0.127, p = 0.019), serum gamma‐glutamyl‐transpeptidase (GGT, B‐coefficient = 0.015, 95% CI: 0.001–0.029, p = 0.032), positivity for HBeAg (B‐coefficient = −0.816, 95% CI: −1.568 to −0.064, p = 0.034), as well as liver fibrosis stage (B‐coefficient = 2.796, 95% CI: 2.501–3.090, p &lt; 0.001), and inflammation activity grade (B‐coefficient = 0.648, 95% CI: 0.162–1.135, p = 0.009) were all independently associated with higher LSM, while no significant association was found between degree of liver steatosis and LSM. Among patients with the same histological fibrosis stage, LSM values did not show any significant difference among patients with absent, mild, moderate or severe steatosis. We conclude that liver steatosis has no significant effect on transient elastography‐measured LSM in CHB patients with normal serum alanine aminotransferase levels.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34902216</pmid><doi>10.1111/jvh.13640</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4984-2631</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1352-0504
ispartof Journal of viral hepatitis, 2022-03, Vol.29 (3), p.196-204
issn 1352-0504
1365-2893
language eng
recordid cdi_proquest_miscellaneous_2610074278
source MEDLINE; Access via Wiley Online Library
subjects Alanine
alanine aminotransferase
Alanine Transaminase
Biopsy
Body mass index
Cholesterol
chronic hepatitis B
Cohort analysis
Cohort Studies
Elasticity Imaging Techniques
Fatty liver
Fatty Liver - pathology
Fibrosis
Hepatitis
Hepatitis B
Hepatitis B e antigen
Hepatitis B, Chronic - complications
Hepatitis B, Chronic - pathology
Humans
Interferon
Liver
Liver - diagnostic imaging
Liver - pathology
Liver Cirrhosis - complications
liver fibrosis
liver steatosis
liver stiffness measurement
Steatosis
title Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T09%3A28%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20liver%20steatosis%20on%20liver%20stiffness%20measurement%20in%20chronic%20hepatitis%20B%20patients%20with%20normal%20serum%20alanine%20aminotransferase%20levels:%20A%20multicentre%20cohort%20study&rft.jtitle=Journal%20of%20viral%20hepatitis&rft.au=Wang,%20Xiao%E2%80%90Dong&rft.date=2022-03&rft.volume=29&rft.issue=3&rft.spage=196&rft.epage=204&rft.pages=196-204&rft.issn=1352-0504&rft.eissn=1365-2893&rft_id=info:doi/10.1111/jvh.13640&rft_dat=%3Cproquest_cross%3E2630567119%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2630567119&rft_id=info:pmid/34902216&rfr_iscdi=true